Opus Genetics IRD
NASDAQ IRD
$4.11 +0.10 (+2.62%)
At close: Oct 21, 2026 · 4:00 PM EDT

Opus Genetics (IRD) Change in Other Operating Liabilities (2019 - 2020)

Updated

Analysis

Opus Genetics (IRD) Change in Other Operating Liabilities (2019 - 2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Liabilities Change (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn -
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn -972.00 Mn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn -
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -32.00 Mn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -112.00 Mn
10 Opus Genetics 391.96 Mn 167.24 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2020 50,000.00
Mar 31, 2020 -900,000.00
Jun 30, 2019 1.35 Mn
Mar 31, 2019 150,000.00
API Access

Opus Genetics Change in Other Operating Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-other-operating-liabilities&ticker=IRD&period=max&api_key=YOUR_API_KEY